Economic Evaluation of Prostatic Urethral Lift

● The PUL and TURP/LASER cohorts:

Inclusion criteria:

• male patient aged over 50 years

• patient who experienced a PUL or TURP/Laser surgery in first line of treatment for asymptomatic BPH, with an International Prostatic Symptom Score > 13, a Peak urineflow rate < 12ml/sec on a voided volume >150ml a Prostate volume >30cc to <80 cc perultrasound.

• patient affiliated to a French health insurance system

Exclusion criteria:

• Patient with current urinary retention, post void residual urine > 250ml,

• Patient with active urinary tract infection at time of treatment,

• Patient with previous Benign Prostatic Hyperplasia procedure,

• Patient with urethral conditions that may prevent insertion and delivery of devicesystem into bladder,

• Patient with previous pelvic surgery or irradiation,

• Patient with history of neurogenic or atonic bladder,

• Patient with biopsy of the prostate within the past 6 weeks,

• Patient with life expectancy estimated to be less than 1 year,

• Patient with history of prostate or bladder cancer,

• Patient with PSA>10ng/ml unless prostate biopsy is negative,

• Patient under guardianship or curatorship,

• Patient intending to move abroad within 1 year after inclusion will not be includedeither,

• Patient participating to another interventional study on benign prostatichyperplasia during the study.

• The SNDS cohort:

Inclusion criteria:

• male patient affiliated to a French health insurance system

• patient aged over 50 years

• patient who experienced a TURP/Laser surgery in first line of treatment for asymptomatic BPH in the same period as patients of the PUL and TURP/LASER cohorts.

Exclusion criteria:

• Patients hospitalized in one of the 6 investigational centers and patients with aprevious BPH procedure,

• patient with a previous pelvic surgery or irradiation,

• patient with history of prostate or bladder cancer within the 2 previous years,

• patient with a biopsy of the prostate within the past 6 weeks,

• patient with a short life expectancy will not be included in the cohort.